Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-DP for Ocular Inflammation and Pain After Cataract Surgery
NCT01666210Phase 2Completed
- Sponsor
- Ocular Therapeutix
- Start
- Oct 2012
- Primary completion
- Aug 2013
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ocular inflammation comparing Dextenza with Placebo (2 arms). Primary endpoints: Absence of Cells in Anterior Chamber of Study Eye at Day 8 and Absence of Pain in the Study Eye at Day 8. Started Oct 2012; status: completed.
02
Drugs
dexamethasone
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT01666210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666210.